Merck
Trade Merck 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About MRK
Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other.
MRK Key Statistics
Stock Snapshot
As of today, Merck(MRK) shares are valued at $112.00. The company's market cap stands at 277.72B, with a P/E ratio of 16.08 and a dividend yield of 2.8%.
As of 2026-04-24, Merck(MRK) stock has fluctuated between $111.50 and $114.03. The current price stands at $112.00, placing the stock +0.4% above today's low and -1.8% off the high.
The Merck(MRK)'s current trading volume is 2.77M, compared to an average daily volume of 9.88M.
During the past year, Merck(MRK) stock moved between $73.31 at its lowest and $125.14 at its peak.
During the past year, Merck(MRK) stock moved between $73.31 at its lowest and $125.14 at its peak.
MRK News
Merck (MRK) announced that the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended, in connection with Merck’s pending acq...
Merck (NYSE:MRK) has agreed to a multi year partnership with Google Cloud, committing up to $1 billion to deploy advanced AI across its global operations. The...
Merck (MRK) and Google Cloud (GOOG) announced a partnership worth up to $1B on Wednesday to implement an agentic platform across the drugmaker's business operat...
Analyst ratings
69%
of 29 ratingsMore MRK News
Merck (MRK) and Google Cloud (GOOG, GOOGL) announced a landmark partnership to enhance Merck’s digital backbone as an AI-enabled enterprise. This multi-year inv...
(RTTNews) - Merck & Co., Inc. (MRK), on Wednesday, announced a multi-year partnership with Alphabet Inc.'s (GOOG), Google Cloud to accelerate its transformation...
The United States market has experienced a robust performance, rising 1.3% over the last week and an impressive 35% over the past year, with earnings anticipate...
Merck (NYSE:MRK) received U.S. FDA approval for IDVYNSO, a new two drug, non INSTI, tenofovir free HIV regimen. The company reported that a late stage trial of...
Clear cell RCC is the most common form of kidney cancer, accounting for roughly 75–80% of cases. Triplet Regimen Misses Primary Endpoints The trial evaluated th...
BofA notes Merck (MRK) and Eisai (ESAIY) announced that the Phase 3 LITESPARK-012 trial evaluating combination regimens for the first-line treatment of patients...
Merck (MRK) and Eisai (ESALF) announced on Tuesday that a late-stage trial evaluating two combination regimens involving the U.S. pharma giant's anti-PD1 inhibi...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.